Medical device and MedTech insights, news, tips and more

Intuitive Surgical Among 1st Big Medtech Companies to Warn of Costly Pandemic Disruptions 

March 19, 2020

stock market

Intuitive said the disruptions it’s felt to date in China, Korea, Taiwan and Italy “do not represent a material portion of our current procedure volume.”

stock market

n Intuitive’s most critical U.S. market, infections are rising and rapid implementation of mitigation strategies more tangibly threatens the company’s goals for the year.

During its most recent earnings call in January, Intuitive forecast between 13% and 16% worldwide procedure growth for 2020. This past weekend, the U.S. Surgeon General echoed an American College of Surgeons recommendation that healthcare providers “thoughtfully review all scheduled elective procedures with a plan to minimize, postpone, or cancel electively scheduled operations, endoscopies, or other invasive procedures” until the outbreak is better under control.

Many of Intuitive’s general surgery, urology, and gynecology procedures could fall under that guidance.

“[W]e anticipate that the procedure volume and system placement disruption will expand as the COVID-19 outbreak intensifies globally,” the company said in the SEC filing.

Most major medtechs have been in wait-and-see mode since offering forecasts during January and February financial reports. At the time, several companies acknowledged possible supply chain disruptions and elective procedure cancellations in China, but they did not take into account a serious threat to core U.S. businesses.

See Full Article: Intuitive Surgical among 1st big medtechs to warn of costly pandemic disruptions | MedTech Dive

Written by: Maria Rachal

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.